Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial

por Singerman, L J, Masonson, H, Patel, M, Adamis, A P, Buggage, R, Cunningham, E, Goldbaum, M, Katz, B, Guyer, D
Publicado 2008